Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma
Authors:
- Hiroichi KobayashiHKHiroichi Kobayashi
- Takeshi KoikeTKTakeshi Koike
- Atsushi NakatsukaANAtsushi Nakatsuka
- Hiroshi KuritaHKHiroshi Kurita
- Junji SagaraJSJunji Sagara
- Shun’iChiro TaniguchiSTShun’iChiro Taniguchi
- Kenji KurashinaKKKenji Kurashina
- 1 January 2005
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 41 (1) , 38-47
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictorOral Oncology, 2003
- Expression of E-cadherin, α-catenin, and β-catenin in the process of lymph node metastasis in oral squamous cell carcinomaBritish Journal of Cancer, 2003
- Gene expression in colorectal cancer and in vitro chemosensitivity to 5‐fluorouracil: A study of 88 surgical specimensCancer Science, 2003
- Increased dihydropyrimidine dehydrogenase activity in breast cancerJournal of Surgical Oncology, 2003
- Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: Multivariate analysisJournal of Surgical Oncology, 2002
- Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: An immunohistochemical and clinicopathologic studyOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2002
- Estimates of the worldwide mortality from 25 cancers in 1990International Journal of Cancer, 1999
- Head and Neck CancerNew England Journal of Medicine, 1993
- Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavityCancer, 1983
- Reporting results of cancer treatmentCancer, 1981